TrialBMJ open2026

Multiarm multistage randomised controlled trial of inflammatory signal inhibitors (MATIS) for patients hospitalised with COVID-19 pneumonia during the UK pandemic.

Lorna Hazell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.